Healthcare ETFs: Specialized Drugs in Greater Demand
July 07, 2015 at 09:30 AM EDT
Johnson & Johnson (NYSE: JNJ), a major component of healthcare sector exchange traded funds, will enjoy greater sales of its specialized drugs. “Based on second-quarter-to-date IMS data, we see the potential for outperformance from several of Johnson & Johnson’s key U.S....